Tata Chemicals Limited Sets Q2 FY27 Results for November 7

Tata Chemicals Limited will consider its Q2 FY27 results on 7 November 2026, following a Q1 FY27 period in which consolidated sales rose 14% year-on-year to ₹4,255 crore while reported net profit fell 81% to ₹60 crore. The board meeting also covers the half-year ended 30 September 2026.

When will Tata Chemicals announce Q2 FY27 results?

Tata Chemicals will hold its board meeting on Saturday, 7 November 2026, to approve unaudited standalone and consolidated financial results for the July-September quarter and first half of FY27. The company informed the NSE about the meeting on 28 October, according to the supplied disclosure.

The company has also scheduled an analyst and investor call on the same day to discuss Q2 and H1 FY27 performance. A separate results-calendar entry says the company is expected to report at 12:15 PM Indian Standard Time. The supplied material does not contain the Q2 financial figures, so sales, profit and margin outcomes for the quarter were not available before the meeting.

The Q2 board meeting is scheduled 38 days after the end of the September quarter. For comparison, Tata Chemicals filed its Q1 FY27 results for the April-June period on 27 July 2026, or 27 days after that quarter ended.

What did Tata Chemicals report in Q1 FY27?

Tata Chemicals reported consolidated sales of ₹4,255 crore in Q1 FY27, compared with ₹3,719 crore in Q1 FY26 and ₹3,438 crore in the preceding March 2026 quarter. This represented year-on-year sales growth of about 14% and sequential growth of about 24%, based on the figures provided.

The supplied consolidated-results table lists EBITDA of ₹555 crore for June 2026, down 14% year-on-year from ₹649 crore in June 2025. It lists net profit at ₹60 crore, down 81% from ₹316 crore a year earlier, after a net loss of ₹2,116 crore in the March 2026 quarter.

The supplied earnings summary contains figures that do not fully align with the displayed consolidated table. It describes Q1 FY27 as a ₹0.67 loss per share and a net loss of ₹170 million, or ₹17 crore, while the table shows ₹60 crore of net profit alongside the same EPS figure. Investors should therefore refer to Tata Chemicals' filed financial statements and results release for the final reported classification and reconciliation.

Why is the Q2 FY27 update important for Tata Chemicals?

The Q2 update is important because it will provide the next disclosed view of Tata Chemicals' operating performance after Q1 sales growth and lower year-on-year EBITDA. The scheduled board meeting covers both the three-month quarter and the six-month period, allowing investors to assess performance across the first half of FY27.

The company operates in the chemicals sector, where the supplied context highlights prior pressure from soda ash prices and freight costs. A Tata Chemicals report on Q2 performance in October 2024 had cited lower soda ash prices and higher freight costs as factors behind a year-on-year profit decline. That earlier report is background information and does not establish the conditions or results for Q2 FY27.

The company had earlier said its trading window would close from 24 September 2026 ahead of the declaration of second-quarter and half-year results. It is due to reopen 48 hours after the results are announced. This is a standard pre-results compliance step disclosed by the company.

How could the results affect Tata Chemicals investors and operations?

Tata Chemicals' Q2 numbers will be the first confirmed financial update for the July-September period, and they will be central to assessing whether Q1 sales growth translated into improved profitability. Until the filing is released, there is no disclosed Q2 revenue, EBITDA, net-profit or earnings-per-share figure on which to measure the quarter's financial performance.

The results calendar in the supplied material shows Tata Chemicals with a market value of ₹15,475 crore. The investor call gives analysts and shareholders an opportunity to hear management discuss the unaudited results and raise questions, but the supplied announcement does not provide guidance, targets or operational forecasts.

The disclosures also matter for investors tracking the wider chemicals industry because they will add updated information on a listed participant's revenue and profit trends. However, the supplied material does not document a share-price move, customer impact, capacity change, employee action or community impact linked to the upcoming Q2 announcement.

What should investors check in the Q2 FY27 filing?

Investors should compare the reported Q2 sales, EBITDA and profit figures with the Q1 FY27 consolidated numbers of ₹4,255 crore, ₹555 crore and ₹60 crore shown in the supplied table. They can also compare the results with the first-quarter year-on-year changes of 14% growth in sales and a 14% decline in EBITDA.

The reported earnings-per-share figure and the reconciliation between profit or loss attributable to shareholders should receive attention because the supplied Q1 table and earnings summary present conflicting net-profit descriptions. The results release, accompanying financial statements and management discussion on 7 November should provide the company’s final disclosed figures for the quarter and first half.

Conclusion

Tata Chemicals is scheduled to approve Q2 and H1 FY27 results on 7 November 2026 after reporting higher Q1 sales but lower year-on-year EBITDA and profit in the figures provided. The pending filing is significant because it will provide the first verified financial data for the September quarter and update the first-half performance record.

The next items to watch are the unaudited standalone and consolidated results, the company’s reconciliation of reported earnings metrics, and comments made during the analyst and investor call scheduled for the same day. Tata Chemicals has not disclosed Q2 figures or financial guidance in the material provided before the meeting.